JBJ. Simon Bell

J. Simon Bell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


J. Simon Bell has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pharmacy Students' and Graduates' Attitudes Towards People With Schizophrenia and Severe Depression

    by J. Simon Bell, Rachelle Johns, Timothy F. Chen

    Objectives. To compare the attitudes of third-year pharmacy students and pharmacy graduates towards people with schizophrenia and severe depression. Methods. Third-year pharmacy students (n = 216) ...


  • Design and Implementation of an Educational Partnership Between Community Pharmacists and Consumer Educators in Mental Health Care

    by J. Simon Bell, Paula Whitehead, Parisa Aslani, Sue Sacker, Timothy F. Chen

    Objective. To design and implement an interactive education program to improve the skill and confidence of community pharmacists in providing pharmaceutical services to people with mental illnesses...


  • Drug-Related Problems in the Community Setting

    by J. Simon Bell, Paula Whitehead, Parisa Aslani, Andrew J. McLachlan, Timothy F. Chen

    Background and objective: Adverse drug events are a leading cause of morbidity in Australia and internationally. People taking psychotropic drugs for mental illnesses may be particularly susceptible. This study aimed to classify and describe pharmacists’ Home Medicines Review (HMR) findings and recommendations for people with mental illnesses. Methods: This was a descriptive study conducted from March to November 2003. General practitioners and community pharmacists practising in two regions of metropolitan Sydney were invited to participate. General practitioners recruitedand referred community-dwelling people with mental illnesses to receive HMRs conducted by accredited pharmacists. Reviewing pharmacists interviewed 49 people in their homes. During the interviews the pharmacists provided drug information, assessed drug knowledge and beliefs, and assessed drug adherence. Pharmacists then produced written referenced reports that outlined drug-, patient-and prescriber-related findings and recommendations. These findings and recommendations were presented to the referring general practitioners at follow-up case conferences. Main outcome measures: Drugs were classified using the Anatomical Therapeutic Chemical Classification System. Pharmacists’ findings and recommendations were classified using the Clinical Pharmacy Activity Classification System. Results: The most common types of nervous system drugs taken by people who received a HMR were antidepressants (n = 39.33%), analgesics (n = 29.24%) and antipsychotics (n = 17.14%). Pharmacists reported 403 findings and made 360 recommendations for 49 people, with 90% of recommendations being accepted by the referring general practitioners. The most common findings related to potential adverse drug reactions (n = 53, for 47% of people), suspected adverse drug reactions (n = 48, for 55% of people), potential interactions (n = 30, for 37% of people), and people taking additional drugs unbeknown to their referring general practitioner (n = 26, for 25% of people). The most common recommendations were to switch a drug (n = 37, for 49% of people), suggest a non-drug treatment (n = 29, for 41% of people) and to suggest a new drug (n = 27, for 49% of people). At the time of referral, general practitioners documented people to be taking 7.8 ± 4.4 (mean ± SD) drugs each (range 1–18). Following home interviews, pharmacists determined people to be taking 9.1 ± 4.8 drugs (range 1–20). This difference wasstatistically significant (p < 0.001). Conclusions: Pharmacists identified a high incidence of drug-related problems among people receiving treatment for mental illnesses. Pharmacists also identified a higher incidence of overall drug use than documented by the referring general practitioners. HMRs and case conferences, undertaken collaboratively by general practitioners and pharmacists, may be a useful strategy to identify drug-related problems among people with mental illnesses.


  • Open Access

    Community pharmacy services to optimise the use of medications for mental illness: a systematic review

    by Simon Bell, Andrew J McLachlan, Parisa Aslani, Paula Whitehead, Timothy F Chen

    The objective of this systematic review was to evaluate the impact of pharmacist delivered community-based services to optimise the use of medications for mental illness. Twenty-two controlled (randomised and non-randomised) studies of pharmacists' interventions in community and residential aged care settings identified in international scientific literature were included for review. Papers were assessed for study design, service recipient, country of origin, intervention type, number of participating pharmacists, methodological quality and outcome measurement. Three studies showed that pharmacists' medication counselling and treatment monitoring can improve adherence to antidepressant medications among those commencing treatment when calculated using an intention-to-treat analysis. Four trials demonstrated that pharmacist conducted medication reviews may reduce the number of potentially inappropriate medications prescribed to those at high risk of medication misadventure. The results of this review provide some evidence that pharmacists can contribute to optimising the use of medications for mental illness in the community setting. However, more well designed studies are needed to assess the impact of pharmacists as members of community mental health teams and as providers of comprehensive medicines information to people with schizophrenia and bipolar disorder


  • From Practice Research to Public Policy—The Ministerial Summit on Health Research

    by Simon Bell

    OBJECTIVE: To report on the outcomes of discussions on the role of research in the improvement of population health that took place at the Ministerial Summit on Health Research. DATA SOURCES: Information was gathered from presentations and discussions at the Ministerial Summit on Health Research conducted in Mexico City November 16–20, 2004. DATA SYNTHESIS: Strategies to strengthen health systems through closer collaboration between researchers and policy makers were debated. Consideration was given to persisting inequalities in health research, including the 10/90 gap (10% of health research expenditure is devoted to diseases responsible for 90% of the world's disease burden), the “know-do” gap (the gap between research knowledge and professional practice), and the divide in access to health information. Adopting measures to address human resource shortages was seen as critical. Participants at the Summit issued “The Mexico Statement on Health Research.” CONCLUSIONS: All stakeholders must develop the political will to share information, resources, and experiences to ensure that practice research and public policy develop in accordance with patients' needs.